Patient Medication Information: uses, side effects, how to take - Reminyl -(4mg)
ABOUT THIS MEDICATION
What the medication is used for:
REMINYL/REMINYL ER is used to treat the symptoms of mild to moderate Alzheimer’s disease (a type of dementia), a disease that alters brain function. The symptoms include progressive memory loss, increasing confusion and behavioural changes, as a result of which it becomes more and more difficult to carry out the activities of daily living.
What it does:
This medication is one of a group of drugs called “cholinesterase inhibitors” which are used to treat the symptoms of mild to moderate Alzheimer’s disease. Dementia due to Alzheimer’s disease is believed to be related to lack of a substance in the brain called acetylcholine, a substance which is thought to be necessary for good brain function. REMINYL/REMINYL ER increases the amount of this substance in the brain, improving memory.
When it should not be used:
If you/the person you are caring for has an allergic
reaction to this medicine or to any of the inactive ingredients in this product
If you/the person you are caring for has ever had an
allergic reaction to a similar type of medicine
If you/the person you are caring for is a child under 18
years of age
Unless you/the person you are caring for has been
diagnosed with Alzheimer’s disease
What the medicinal ingredient is:
galantamine hydrobromide
What the nonmedicinal ingredients are:
REMINYL tablets: Lactose monohydrate, microcrystalline cellulose, colloidal anhydrous silica, crospovidone, magnesium stearate, hypromellose, propylene glycol, talc and titanium dioxide. The 4 mg tablet also contains yellow ferric oxide. The 8 mg tablet also contains red ferric oxide. The 12 mg tablet also contains red ferric oxide and FD & C yellow #6 (orange yellow S aluminum lake).
REMINYL ER extended release capsules: Gelatin, diethyl phthalate, ethylcellulose, hypromellose, polyethylene glycol, titanium dioxide and sugar spheres (sucrose and starch). The 16 mg capsule also contains red ferric oxide. The 24 mg capsule also contains red ferric oxide and yellow ferric oxide.
What dosage forms it comes in:
Tablets: 4 mg, 8 mg, 12 mg
Extended release capsules: 8 mg, 16 mg, 24 mg
WARNINGS AND PRECAUTIONS
BEFORE you use REMINYL/REMINYL ER, talk to your doctor or pharmacist if you have any of the following problems or conditions:
- heart disorders
- stomach ulcer or history of ulcer
- acute abdominal pain
- some disorders of the nervous system (like epilepsy)
- respiratory diseases that interfere with breathing (like asthma)
- a recent operation on the gut or bladder or difficulties in passing urine
- an increased risk of developing ulcers (for example, you are taking non-steroidal anti-inflammatory drugs (NSAIDs) or high doses of acetylsalicylic acid [ASA (Aspirin®)]
- liver or kidney problems
pregnant or possibly pregnant
- breast-feeding
having an operation with general anesthesia
(medication that puts you to sleep)
- taking any other medications, including prescription, over-the-counter, herbal medicines or natural health products
If any of these happen after you start taking your medication, make sure you tell your doctor.
REMINYL/REMINYL ER, as well as Alzheimer’s disease itself, can affect the ability to drive or operate machinery. Therefore, this matter should be discussed with the doctor.
INTERACTIONS WITH THIS MEDICATION
Always tell your doctor, nurse or pharmacist if you are taking any other medicines, either prescription, over-the-counter, herbal medicines, or natural health products, because taking some medicines together can be harmful.
Tell your doctor if you are taking:
- drugs for diarrhea, Parkinson’s disease, or airway spasms
- drugs for certain heart problems, such as digoxin
- certain drugs taken for depression such as paroxetine
- ketoconazole, a drug used to treat fungal infections
PROPER USE OF THIS MEDICATION
Usual dose:
REMINYL/REMINYL ER is started at a low dose and then slowly increased to the most suitable dose, depending on how you respond to the treatment. REMINYL tablets should be taken twice a day, preferably with the morning and evening meals. REMINYL ER extended release capsules should be taken once a day in the morning, preferably with food. Be sure to drink plenty of liquids during your treatment to keep yourself hydrated.
REMEMBER: This medicine is for you. Only a doctor can prescribe it for you. Never give it to someone else. It may harm them even if their symptoms appear to be similar to yours.
Overdose:
If you have taken more medication than you have been told, contact either your doctor, hospital emergency department, or nearest poison control centre immediately, even if you do not feel sick.
Missed dose:
If you forget to take a dose, do not worry, wait and take the next dose at the usual time. Do NOT take two doses at once.
If your treatment is interrupted for several days or longer, do NOT re-initiate treatment without contacting your doctor.
SIDE EFFECTS AND WHAT TO DO ABOUT THEM
If side effects occur, they are mainly experienced early in the treatment or when the dose is increased. Most tend to disappear gradually as the body adapts to the treatment; for example, nausea (feeling sick) and vomiting (being sick) generally pass after a few days. However, you should tell your doctor about any side effects, especially if they persist.
Other possible side effects include:
abdominal pain, diarrhea, indigestion, decreased
appetite
- difficulty swallowing
- bleeding in the digestive system
- weight loss
- low blood potassium
- low blood pressure
- dehydration (sometimes severe)
behavioural disturbances like agitation, aggression and
hallucinations
- weakness
- fever
- malaise
- leg cramps
- tingling in the hands or feet
- ringing in the ears
- headache
- dizziness
tiredness, sleepiness or sleeplessness
- confusion
- runny nose
- urinary tract infection
- falling, sometimes resulting in injury
- fainting and fluttering of the heart
- trembling
- heart rhythm disorder
- slow heartbeat
- heart attack
- stroke
- other side effects described below
| SERIOUS SIDE EFFECTS, HOW OFTEN THEY | ||||||
| HAPPEN AND WHAT TO DO ABOUT THEM | ||||||
| Symptom / effect | Seek medical attention immediately | Stop taking drug and call your doctor or pharmacist | ||||
| Only if severe | In all cases | |||||
| Uncommon | Irregular beating of the heart | 9 | ||||
| Pain or tightness in the chest | 9 | |||||
| Seizures | 9 | |||||
Sudden weakness or numbness of the face, arms or legs, especially on one side, slurred speech or vision problems | 9 | |||||
| Rare | Symptoms of allergic reaction such as skin rash, or swelling of the face, lips or tongue | 9 | ||||
| Thoughts of suicide or self-harm | 9 | |||||
| Very Rare | Blood in the stools, black, tarry stools, or vomiting blood | 9 | ||||
If you are caring for a patient with Alzheimer's disease who has new symptoms you should discuss them with his or her doctor.
If you feel unwell in the ways described in this section or any other way, or have any symptoms that you do not understand or find distressing, you should contact your doctor immediately. If you experience side effects that are severe, stop taking the drug and contact your doctor immediately.
This is not a complete list of side effects. For any unexpected effects while taking REMINYL/REMINYL ER, contact your doctor or pharmacist.
HOW TO STORE IT
As with all medicines, REMINYL/REMINYL ER should be kept in a safe place where children cannot reach it. Also keep this medicine in a cool dry place (15 to 30°C). Medicines can be kept for a limited period only. Therefore, do not use REMINYL/REMINYL ER after the date (month and year) printed after “EXP”, even if it has been stored properly. Always return old medicines to your pharmacist.
REPORTING SUSPECTED SIDE EFFECTS
To monitor drug safety, Health Canada through the Canada Vigilance Program collects information on serious and unexpected side effects of drugs. If you suspect you have had a serious or unexpected reaction to this drug you may notify Canada Vigilance:
By toll-free telephone: 866-234-2345
By toll-free fax: 866-678-6789
Online: www.healthcanada.gc.ca/medeffect By email: CanadaVigilance@hc-sc.gc.ca
By regular mail:
Canada Vigilance National Office
Marketed Health Products Safety and Effectiveness Information Bureau
Marketed Health Products Directorate
Health Products and Food Branch
Health Canada
Tunney’s Pasture, AL 0701C
Ottawa ON K1A 0K9
NOTE: Should you require information related to the management of the side effect, please contact your health care provider before notifying Canada Vigilance. The Canada Vigilance Program does not provide medical advice.
MORE INFORMATION
This document plus the full Product Monograph, prepared for health professionals can be found at:
http://www.janssen-ortho.com
or by contacting the sponsor, Janssen-Ortho Inc., at: 1-800-567-3331
Janssen-Ortho Inc.
Toronto, Ontario M3C 1L9
Last revised: July 24, 2008
*All trademark rights used under license
